MedPath

Physiological and Clinical Changes in NHF Therapy

Not Applicable
Completed
Conditions
Interstitital Lung Disease
Hypercapnia
Chronic Obstructive Pulmonary Disease
Interventions
Device: Nasal Highflow (NHF)
Registration Number
NCT02504814
Lead Sponsor
University of Leipzig
Brief Summary

The study explores the changes in pressure, volume and in hypercapnia in patients with COPD and ILD. The investigators will use different application forms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • COPD, ILD
Exclusion Criteria
  • Unstable disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ventilatory effectsNasal Highflow (NHF)measuring mean airway pressure, breathing volumes and decrease in hypercapnia
Primary Outcome Measures
NameTimeMethod
changes in mean airway pressure (mbar)1 month
changes in tidal and minute volume (l)1 month
changes in breathing frequency (beats/ minute)1 month
Secondary Outcome Measures
NameTimeMethod
changes in partial pressure of carbon dioxide (CO2) in arterial blood (pCO2)4 month

Trial Locations

Locations (1)

Jens Bräunlich

🇩🇪

Leipzig, Sachsen, Germany

© Copyright 2025. All Rights Reserved by MedPath